Recent Headlines
MD Stem Cells Begins Intravitreal Stem Cell Treatments for Severe Visual Loss
New Intravitreal Stem Cell Injection Approach to Improve Vision is Now Available through MD Stem Cells. - February 15, 2013 - MD Stem Cells
Xeno Diagnostics, LLC Receives Award for Laboratory Excellence
Xeno Diagnostics, LLC Recognized for Quality Laboratory Services - February 15, 2013 - Xeno Diagnostics, LLC
Greenwerkz Releases R4 Ultra-High CBD, Non-Psychoactive Strain as "Open Source"
Greenwerkz' high CBD/low THC strain genetics to become available to patients and medical marijuana centers (MMCs) in Colorado, free of charge. - February 14, 2013 - Greenwerkz
SFL’s Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013. - February 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits
AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity – the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits. The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a... - February 09, 2013 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, is Offering Glycan Arrays for Multiple Analysis of Glycan-Related Interactions
MoBiTec Germany, in cooperation with the Japanese company Sumitomo Bakelite Co. Ltd., is offering to its European customers Glycan Arrays that are useful for studies on the interaction of microorganisms, analysis of glycan-binding proteins, autoantibodies and more. - February 09, 2013 - MoBiTec GmbH
BANG® – as Official Energy Drink of NHL Florida Panthers & BB&T Center
It was just announced that VPX’s BANG® will be named official energy drink of the NHL Florida Panthers and the BB&T Center, formerly known as the Bank Atlantic Center. - February 07, 2013 - VIRUN
Billion Cell Milestone Reached in Stem Cell Treatment
MD Stem Cells Reports Almost Two Billion Cells Used in Eye Stem Cell Treatment in Florida. - February 07, 2013 - MD Stem Cells
Molecular Medicine Tri-Conference 2013 - Complimentary Hall Passes Now Available
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference (Triconference.com/hallpass) - February 02, 2013 - Cambridge Healthtech Institute
CHI Releases List of Delegates for Targeting Cancer Stem Cells Symposium in San Francisco, CA
To be held on February 11-12, 2013 at the Moscone North Convention Center, San Francisco, CA - Part of the Molecular Med TRI-CON 2013. - January 26, 2013 - Cambridge Healthtech Institute
Tampa Bay Surgeons Offer Virtually Scarless Weight-Loss Procedure
Sun Coast Bariatrics is using the SPIDER® Surgical System to perform single-incision sleeve gastrectomy. - January 26, 2013 - TransEnterix
Optic Nerve Vision Loss Reversed with New Stem Cell Treatment
MD Stem Cells helps nearly blind car accident victim regain her sight in Florida and see her mother’s face again- other neurologic benefits reported as well. - January 24, 2013 - MD Stem Cells
Novel Health Strategies Announces Publication of Annual and Recurring Strategy Overview on Emerging Life Sciences Market Trends
Novel Health Strategies Study Shows Oncology, Diabetes and Auto-Immune Indications Driving Growth of the Biotech Sector; More Products Facing Market Access Challenges. - January 24, 2013 - Novel Health Strategies
MD Stem Cells Improves Myopic Macular Degeneration with New Stem Cell Treatment
MD Stem Cells helps Australian patient travel half way around the world for stem cell treatment in Florida to achieve significant improvement in vision. - January 14, 2013 - MD Stem Cells
AnaSpec Offers a Wide Selection of SYBR® qPCR MasterMixes and Core Kits
AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. - January 12, 2013 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, is Offering TurboLigation™ Kit, Enabling Quick Ligation of DNA Molecules in Just 5 Minutes at a Bargain Price
Combining heterologous DNA molecules is a key process in most traditional molecular cloning experiments. This process, facilitated by the enzyme DNA ligase, usually takes about 16 hours. With the TurboLigation™ Kit the reaction time is greatly reduced down to just 5 minutes without compromising the efficiency. - December 22, 2012 - MoBiTec GmbH
2012 - An Award-Winning Year for SFL
This year, SFL’s multifunctional expertise has been independently recognised through two important business awards. In July, Shayesteh Fürst-Ladani, Managing Director of the company, received the Open University Business School’s Alumni Award Outstanding Contribution to an... - December 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
MoBiTec GmbH, Germany, Introduces New Multiplex Secretion Gene Expression System for Bacillus subtilis
Bacillus subtilis has become an increasingly popular host for recombinant protein expression. With its ability to secrete protein directly into culture media, and designation by the U.S. Food and Drug Administration as an organism that is Generally Regarded As Safe (GRAS), the majority of industrially-produced enzymes are expressed in Bacillus species such as B. subtilis. To address this, MoBiTec introduces the new Bacillus subtilis Multiplex Secretion Expression System. - December 13, 2012 - MoBiTec GmbH
Highly Sensitive SensoLyte® HDACs and HATs Assay Kits for Epigenetics Research
AnaSpec has developed a series of highly sensitive assay kits for the detection of the activities of HDAC (Histone Deacetylase), SIRT (Sirtuin) 1 & 2 or HAT (Histone Acetyltransferases). - December 07, 2012 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® ThT Aβ42 & Aβ40 Aggregation Kits
AnaSpec has developed the SensoLyte® ThT Aß40 and Aß42 Aggregation kits to provide a convenient and standard method for measurement of Aß40 and Aß42 aggregation, respectively. - December 06, 2012 - AnaSpec, EGT Group
VPX Sports® Introduces BANG® – an Intelligent Beverage Design Aimed to Change Typical “Energy Drink” Perception
The beverage innovators at VPX® have re-defined the “energy drink” category by introducing BANG® -- a novel, great-tasting 16 ounce carbonated beverage formulated to fuel the brain and body. “BANG® is not your typical high sugar, health robbing beverage,” rather, BANG® consists of several patent-pending compounds and patented compositions intelligently designed to deliver results “…without the sugar-induced metabolic mayhem and crash.” -Jack Owoc, Chief Executive & Science Officer for VPX Sports - November 30, 2012 - VIRUN
SFL Selected as Finalist in the British-Swiss Business Awards
SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards. - October 13, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism
Autism Therapeutics LLC ("Autism Therapeutics") announced today that the Type C Guidance Meeting with FDA to discuss the ZYDIS® ODT Fluoxetine / Autism program has taken place. The FDA and Autism Therapeutics discussed the completion of the Phase III development of the program... - October 09, 2012 - Autism Therapeutics LLC
OsoBio Appoints Alan P. Heim as Vice President of Human Resources
OSO BioPharmaceuticals Manufacturing, LLC, has appointed Alan P. Heim as vice president of human resources. In his capacity, Heim administers all policies and programs that affect personnel at OsoBio, including issues such as organizational planning; recruitment, hiring and training; employee... - October 05, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
SignaBlok Awarded NCI Grant to Test New Approach to Lung Cancer Treatment
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Cancer Institute (NCI) to develop novel and first-in-class agents in lung cancer. - October 03, 2012 - SignaBlok, Inc.
MoBiTec to Exhibit at the 16th Joint Meeting of the Signal Transduction Society (STS) 2012 in Weimar, Germany, to Represent Echelon Biosciences Inc. And Bellbrook Labs
Tools for Lipid Research from Echelon Biosciences Inc., and BellBrook Labs' Transcreener HTS Assays - a Universal, High Throughput Screening Platform for Enzymes based on direct Detection of Nucleotide Enzyme Products with Far Red FI, FP and TR-FRET Readouts - are some of the Highlights MoBiTec is going to Present at this Years STS Meeting in Weimar, Germany. - September 23, 2012 - MoBiTec GmbH
SFL’s Managing Director Invited to Speak at World Medtech Forum
Shayesteh Fürst-Ladani, Managing Director of the SFL will speak on European Day at the World Medtech Forum in Lucerne, Switzerland. - September 22, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
New Product Launch - Green Leaf Labs
Before the end of 2012 new N-(2-Hydroxyethyl) hexadecanamide products will be available worldwide with updated product specifications. - September 12, 2012 - Green Leaf Labs
Breakout Discussion Groups Announced at CHI's Immunogenicity Summit 2012 in Bethesda, MD, Oct. 10-12
Delegates now have the option to choose from 10 moderated breakout discussion groups at this industry leading event facilitated by FDA and industry and academic experts. - September 11, 2012 - Cambridge Healthtech Institute
SFL’s Managing Director and Head of UK Office to Speak at DIA Combination Products Workshop in Basel, Switzerland
SFL’s team to provide delegates with an understanding of the regulatory framework for drug/device combinations and drug/companion diagnostics in the EU. - September 08, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
MoBiTec GmbH, Germany, Closes Distribution Agreement with VIDIA Ltd., Czech Republic, to Distribute ELISA Kits for Human Medicine and for Environmental Monitoring
VIDIA Ltd. is a private Czech biotechnological company with its own research and development department that closely cooperates with The Academy of Sciences of the Czech Republic, hospitals and universities. VIDIA is producer of diagnostic kits for human medicine and for environmental monitoring. MoBiTec distributes products from several international companies in Germany and across the world, next to its own product line. - September 07, 2012 - MoBiTec GmbH
VIRUN® Receives Eighth Notice-of-Allowance for Patent Applications and Introduces New “Space” Within Industry
After only a short while, VIRUN has obtained numerous Notice-of-Allowances and several patent grants for its nano-encapsulation technologies that allow non polar compounds, such as CoQ10 and Omega-3 EPA DHA, to dissolve clearer and shelf stable into foods and beverages. With this increase in patent proliferation, VIRUN introduces the NUTRA-BIOsciences™ platform to accelerate the expansion and exclusivity of new and added-value food/beverage products. - August 30, 2012 - VIRUN
AnaSpec Introduces SensoLyte® Enterokinase Assay Kits
AnaSpec, EGT Group is pleased to announce the release of two assay kits for quantitating enterokinase enzymatic activity – the SensoLyte® 520 and SensoLyte® Rh110 Enterokinase Activity Assay Kits. The former is a FRET (fluorescence resonance energy transfer)-based assay employing a... - August 30, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Speedy 28-Day Custom Polyclonal Antibody
When traditional protocols can take 70+ days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec, EGT Group asked, "Is there a way to develop custom antibodies faster without sacrificing quality in the finished product?" Here's the answer. The Speedy... - August 24, 2012 - AnaSpec, EGT Group
AnaSpec Offers Phosphospecific Antibodies Production
Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that results in the modification of the activity of the phosphorylated molecule by inducing small conformational changes within the molecule.1-2 Catalyzed by protein kinases, phosphate groups can be added via the... - August 17, 2012 - AnaSpec, EGT Group
Pediatric Brain Tumor Foundation Names Robin Boettcher CEO
The Board of Directors of the Pediatric Brain Tumor Foundation (PBTF) has named Robin Boettcher as chief executive officer. She succeeds PBTF co-founder Dianne Traynor, who died last month. Boettcher, who begins her new role on Sept. 10, brings extensive nonprofit experience, including leadership positions with the National Parkinson Foundation and the Leukemia & Lymphoma Society. - August 16, 2012 - Pediatric Brain Tumor Foundation
VIRUN® Closes $2.1 Million Series-A Funding to Bolster Innovation and World-Wide Expansion
After almost 10 years of self-funding growth and business expansion, VIRUN is ready to further-illuminate its presence and capitalize on its patented technology portfolio and product development. - August 02, 2012 - VIRUN
AnaSpec Highlights Beta-Amyloid (1-40) Peptides
ß-Amyloid (1-40) together with ß-Amyloid (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs, with Ab (1-42) being more neurotoxic. These undergo post-secretory aggregation and deposition in the Alzheimer’s diseased... - August 01, 2012 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, Closes Distribution Agreement for Stem Cells, Primary Cells and Reagents with Cyagen Biosciences Inc., China, for the German Market
A leading stem cell producer, Cyagen offers one of the most comprehensive lists of research-use stem cells. Other products include cell culture and differentiation media, cell culture supplements, and an assortment of related research reagents. - July 29, 2012 - MoBiTec GmbH
AnaSpec Highlights Beta-Amyloid (1-42) Peptides
Harnessing over a decade's worth of experience and a multi-level technology platform that includes peptides, antibodies, dyes and assay kits, AnaSpec, EGT Group is one of the world's most trusted sources of integrated proteomic solutions specifically designed for Alzheimer's Disease... - July 25, 2012 - AnaSpec, EGT Group
FyMed Demonstrates Superiority of FY101C Over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed, Inc. today announced results from comparative in-vivo studies of FY101C, its lead NSAID candidate, which demonstrated significant superiority to conventional NSAIDs in terms of efficacy and safety in the management of acute and chronic pain and inflammation. - July 25, 2012 - FyMed Inc
MoBiTec GmbH Introduces New High Performance Expression Vectors for Bacillus Subtilis
MoBiTec GmbH, Germany, further expands its unique portfolio of non-E. coli expression vectors. The new Pgrac100 vectors for gene expression in Bacillus subtilis complement the current product line by more efficient tools. Available are vectors with His-tag and Strep-tag for easy purification of proteins generated in the cytoplasm. - July 20, 2012 - MoBiTec GmbH
SFL’s Managing Director Receives Open University Business School’s Alumni Award for Outstanding Contribution to an Organisation 2012
The Open University Business School Alumni Network nominates and elects individuals that demonstrate best the application of learnings from the Open University MBA training and achievement of outstanding results. - July 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
TransEnterix Takes Minimally Invasive SPIDER Surgical System to India
Laparoscopic surgeon Dr. Michel Gagner headlines symposium in New Delhi's Max Institute. - July 12, 2012 - TransEnterix
SignaBlok Awarded NIH Grant to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis. - July 12, 2012 - SignaBlok, Inc.
MoBiTec GmbH Introduces First Secretion Vectors for the Lactococcus lactis Gene Expression System NICE®, Developed by NIZO Food Research
NIZO food research has developed the first commercially available secretion vectors for the widely used Nisin Controlled gene Expression system NICE®. The NICE® System is a Gram-positive gene expression system for Lactococcus lactis already used by many labs all around the world. The NICE System as well as the secretion vectors are marketed worldwide by Germany-based MoBiTec GmbH. With these new secretion vectors MoBiTec expands its rich portfolio of non-E. coli vectors and expression systems. - July 04, 2012 - MoBiTec GmbH
AnaSpec Introduces SensoLyte® Beta-Amyloid ELISA Kits
AnaSpec, EGT Group is pleased to announce the release of the SensoLyte® ELISA kits for the quantification of human and mouse/rat β-Amyloid (1-40) or (1-42) peptide. Compared to similar kits in the industry, these kits are a one-step assay optimized to detect human or mouse/rat beta-Amyloid... - June 29, 2012 - AnaSpec, EGT Group
AnaSpec Offers PTM Peptide Synthesis
Proteins undergo post-translational modifications (PTM) as a mechanism to expand the coding capacity of genes.1 PTMs found in histone “tails” (amino termini) such as acetylation, methylation and phosphorylation affect chromatin structure and exquisitely regulate gene... - June 27, 2012 - AnaSpec, EGT Group
SFL’s Managing Director Invited to Chair Session and Speak at DIA 48th Annual Meeting in Philadelphia
SFL's Managing Director updates DIA attendees on Revision of European Medical Device Directives. - June 27, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
AnaSpec Offers Industry’s Longest Wavelength Assay Kit for HDAC Dectection
Current HDAC assay kits have been based on a short wavelength substrate whose detection is darkened by the presence of autofluorescence interference. SensoLyte® has ushered in the dawn of ultra-sensitivity. AnaSpec, EGT Group’s SensoLyte® 520 HDAC Activity Assay Kit is the... - June 20, 2012 - AnaSpec, EGT Group